CreditSights vs BioPharma Edge

Covering markets that move requires research that moves with you. The CreditSights Mobile app is designed to help you stay connected with the market insights that drive your day. Through your mobile phone or tablet, you can now access our independent credit research and comprehensive market insights to make timely, well-informed decisions and better manage risk. Top Features: • Access your feed directly from your mobile device • View individual companies with valuable info and metrics • Save articles and read them offline • Receive notifications when relevant research is published • Filter content by region, credit grade, or sector • Review Top Read and most recent research CreditSights empowers more than 40,000 financial professionals among the world's largest institutions with the credit-risk tools, independent research and comprehensive market insights they need to make well-informed credit decisions. Setting the standard for global credit research since 2000, we provide timely data, news, and unbiased analysis of over 30,000 issuers around the world. Over 90% of the world's largest institutions use CreditSights enabling market participants to know more, risk better and ultimately create value. Note: This app is for CreditSights subscribers and current login credentials are required to sign in.

BioPharma Edge is a curated biotech stock research platform built specifically for self-directed investors who want to navigate one of the market's most volatile, and rewarding sectors with greater clarity and confidence. Rather than reacting to daily market moves, BioPharma Edge follows the clinical, regulatory, and commercial catalysts that shape company outcomes — trial readouts, FDA decisions, and the key milestones ahead of them. Every company we cover is tracked through a consistent research framework; from the moment a catalyst is identified to the moment the thesis is settled. Key Features • Pipeline Follow curated, high-impact biotech stocks through a disciplined research framework. Every company record includes a structured Research Snapshot, Upcoming Catalyst, Opportunity Snapshot, and Outcome Snapshot — plus a full Research Brief covering the science, the competitive landscape, and the milestones that matter. • Dashboard Uncover insights across the whole pipeline through structured analytics. Filter by thesis type, conviction, risk profile, therapeutic area, catalyst timing, and performance across three report groups: Performance, Pipeline, and Catalysts. • Playbook Learn the frameworks behind catalyst-driven biotech investing through educational lessons spanning biotech fundamentals, catalyst investing, clinical data interpretation, portfolio strategy, BioPharma Edge Platform Intelligence, and real-world case studies. • Workspace Start each session with what deserves your attention: upcoming catalysts by 30, 60, and 90-day windows, research performance, benchmark standing, and the day's pipeline movers. Built on Three Principles • Independent Research — Human-reviewed biotech research grounded in science, data, and disciplined judgment. • Conviction, Not Coverage — We prioritize high-conviction biotech opportunities over broad market coverage. • Transparent Performance — Every research thesis is recorded at initiation and left unrevised, then scored against what actually happened. Wins and losses alike. When we initiate research, we record our thesis type, conviction, risk profile, and upside potential — and we never revise them. When the catalyst resolves, the outcome is recorded beside the original call. You can see what we expected, what happened, and whether we were right. Subscription Options BioPharma Edge offers full, unrestricted access with zero subscriptions, trial periods, or paywalls. Every user receives complete access to the research catalog across all statuses, Research Briefs, Dashboard analytics, alerts, and the full Playbook. All you need is an email address—sign-in is completely passwordless via a secure direct link. Important Information BioPharma Edge is provided for informational and educational purposes only. It does not provide investment, legal, tax, or financial advice, and nothing in the app constitutes a recommendation to buy, sell, or hold any security. BIOVIEW CAPITAL LLC is not a registered investment adviser or broker-dealer. Performance figures shown in the app are hypothetical and model-based, calculated from reference prices rather than actual trades. They exclude fees, slippage, and taxes. Past performance does not indicate future results. Biotechnology investing involves substantial risk, including the risk of total loss. Always conduct your own independent research before making investment decisions.